mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.1 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |
mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.1 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.075 |
0.1 |